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MinireviewPlasticity of the Visual Cortex andFrank Sengpiel
Over the last 50 years, research into the developmental
plasticity of the visual cortex has led to a growing under-
standing of first the causes and then of the underlying
cellular mechanisms of amblyopia or ‘lazy eye’, the com-
monest childhood disorder of vision. While it is widely
believed that amblyopia cannot be treated successfully
after the age of about 7, recent animal studies have
demonstrated that visual cortex plasticity can be restored
or enhanced later in life, paving the way for new strategies
for the treatment of amblyopia that attempt to remove
molecular brakes on plasticity. In addition, both animal
and human work has established that amblyopia is not
simply a monocular deficit, and therefore the most pro-
mising new non-invasive approaches force the two eyes
to cooperate as opposed to conventional procedures
that severely penalise the good eye.
Introduction
Since the pioneering work by Hubel and Wiesel in the 1960s,
the visual system has become a key paradigm for studies of
neural plasticity, and added clinical interest stems from
efforts to find better treatments for amblyopia (‘lazy eye’),
a common developmental disorder of vision affecting
2–4% of the population. Amblyopia is defined clinically as
reduced visual acuity despite optimal refraction, in the
absence of a persisting ocular pathology. It is due to disrup-
tion of normal visual development in childhood and is
accompanied by one or more known amblyogenic factors,
such as strabismus (crossed eyes), anisometropia (different
refractive errors in the two eyes) and cataract. Amblyogenic
factors interfere with normal development of the visual path-
ways during a critical period of maturation [1]. It is thought
that amblyopia is caused by a mismatch between the im-
ages seen by the two eyes, resulting in vision in one eye be-
ing suppressed [2]. Because amblyopia is the result of
maldevelopment of structure and function of the visual cor-
tex, it is important to understand normal cortical develop-
ment and plasticity in order to make progress in its
treatment.
Why Is Plasticity Important?
The visual system adapts on a second-by-second level to
characteristics of the visual environment such as luminance,
contrast, colour and speed of motion but it also undergoes
lifelong changes, for example, in response to degradation
of input through one eye. Every individual needs to adapt
to their environment in a way that is far too complex to be en-
coded in a set of genes. This process is especially important
during ontogeny; once an individual has reached puberty it
is usually complete. The critical period is the time during
early postnatal life when the development and maturation
of brain functions such as sensory processing or language
is particularly dependent on and shaped by experience orSchool of Biosciences and Neuroscience and Mental Health Research
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stimulation during this period, the affected function(s) may
not develop at all, or not develop properly. The focus of
studies of the neurobiological basis of visual cortex plasticity
as well as of its application to clinically relevant conditions
such as amblyopia is ocular dominance (OD) plasticity, a
shift in the relative strength of neuronal responses to left
and right eye stimulation. It is typically probed by monocular
deprivation (MD), the patching or suturing of the lids of one
eye. OD plasticity on a short timescale (of hours) involves pri-
marily functional, synaptic changes which may be reversible
while long-term plasticity involves structural modifications
that tend to be more persistent.
Functional Plasticity
Work by Bear and colleagues established that the NMDA
receptor as a ‘coincidence detector’ plays a key role in medi-
ating at least some aspects of functional plasticity, since
blocking NMDA receptor function abolished the OD shift
towards the open eye normally observed following MD
during the critical period [3]. Moreover, NMDA receptor-
mediated plasticity is bidirectional, such that the changes
to synaptic transmission caused by one form of visual
experience (e.g., complete darkness) can be reversed by
exposure to a different form of experience (e.g., a normal
day–night cycle) [4].
More recently, the key role of GABAergic intracortical
inhibition in controlling the time course of the critical period
has been revealed. Work by Hensch and colleagues showed
that a threshold level of synaptic GABA is required to open
the critical period since mice lacking the GABA synthesising
enzyme glutamic acid decarboxylase (GAD) 65 never exhibit
OD plasticity [5]. Infusion into the visual cortex of the GABA
agonist diazepam restores ODplasticity in GAD65 knock-out
mice at any age. Conversely, attaining a threshold level of
intracortical inhibition precipitates closure of the critical
period such that GAD65 knock-out mice whose GABAergic
transmission has been enhanced early in life become insen-
sitive to monocular deprivation as adults [6]. Subsequent
work has shown that it is the balance of excitation and
inhibition (E/I) which controls the time course of the critical
period. Interventions that enhance or accelerate the matura-
tion of inhibition, such as brain-derived neurotrophic factor
(BDNF) overexpression or benzodiazepines, bring it forward
while interventions that delay or decrease inhibition, such as
dark-rearing or GAD65 knock-out, shift the critical period
back [7].
Structural Plasticity
Synaptic modifications need to be consolidated in order to
leave a lasting experience-dependent ‘trace’. It has been
known for some time that monocular deprivation leads to
rapid remodelling of geniculocortical afferents, in particular
a retraction of those representing the deprived eye [8].
More recent research has focused on postsynaptic changes,
consisting of an increase in spine motility and spine turn-
over, the addition of new and elimination of existing spines
[9]. The extracellular protease tissue plasminogen activator
(tPA) plays a key role in spine motility; mice in which its
gene has been deleted lack OD plasticity, but this can be
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Figure 1. Daily binocular vision required to reverse or prevent
amblyopia.
(A) Visual acuity of the amblyopic eye of kittens that had been monoc-
ularly deprived for 6 weeks and then part-time reverse occluded for
6 weeks. During the latter period the animals had 7 hours of daily light
exposure during which they wore a patch in front of the non-deprived
eye for the time indicated on the abscissa. Fitted line represents the
best fit of a cubic polynomial (R2 = 0.832). Note that the deprived eye
recovers the greatest acuity when both eyes are open for about half
of the time. Data replotted from [17]. (B) Cortical territory dominated
by the part-time deprived eye of kittens that wore an eye patch for a
certain amount of time every day while having binocular exposure
(plotted on the abscissa) for the remaining hours of light (total daily light
exposure was either 7 h or 3.5 h). Fitted line represents the best fit of a
logarithmic function (R2 = 0.589). Data replotted from [18]. (C) Relation
between objectively measured mean daily patching of the fellow eye
and proportion of deficit corrected in the amblyopic eye. Red line
and symbols, children aged <4 years; blue line and symbols, children
aged 4–6 years; fitted lines represent LOWESS (locally weighted
smoothed) lines of best fit. Reproduced from [21] with permission
from BMJ Publishing Group Ltd.
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R937restored by the exogenous administration of tPA [10]. More-
over, the spine loss normally observed after three days ofMD
during the critical period is reduced [11]. Important structural
changes occurring in the extracellular matrix towards the
end of the critical period are thought at least in part to be
responsible for the decline in experience-dependent plas-
ticity. Key among these is the increase in cross-linked chon-
droitin sulphate proteoglycans (CSPGs) such as aggrecan
which contribute to the gradual elaboration of an insoluble
matrix in the maturing brain. Aggrecan expression has
been shown to be activity (and therefore experience) depen-
dent [12]. Furthermore, CSPGs form dense perineuronal nets
in particular around GABAergic parvalbumin-positive cells,
thus inhibiting axonal growth. A second brake on structural
plasticity is Nogo-66 receptor (NgR) signalling mediated
through the low-affinity neurotrophin receptor p75, with
which NgR forms a complex and through which it activates
the Rho pathway, again inhibiting neurite growth [13].
Although the absolute abundance of the NgR ligand Nogo-
A in the visual cortex does not change much over the time
course of the critical period, abundance in layer 4 (which
receives the retinal inputs) increases significantly [14].
How Can Understanding Plasticity Help with the
Treatment of Disorders of Vision?
Until quite recently eye care professionals insisted on treat-
ing amblyopia by full-time patching of the fellow, non-ambly-
opic eye: ‘‘The value of the time proven constant occlusion
treatment of the sound eye remains unchallenged even
though minor modifications have become necessary to pre-
vent occlusion amblyopia in infants and young children.
Part-time occlusion and penalization are of ancillary value
but cannot be considered equal in effectiveness to constant
occlusion’’ [15]. The rationale behind patching is that
depriving the fellow eye of vision eliminates suppression of
vision in the amblyopic eye and allows visual experience to
promote recovery of visual acuity in that eye; however, this
approach has significant shortcomings in that it treats
amblyopia largely as a monocular disease [1]. Recent
research has not only led to a revision of conventional patch-
ing treatment but suggests a number of alternative treatment
avenues that opened up the possibility of improved visual
outcomes in teenage and early adulthood.
In conceptual terms the emphasis has moved from one of
binocular competition to one of binocular cooperation. The
first experimental evidence for this revised view came from
a study which investigated recovery from amblyopia in cats
by restoring binocular vision after a period of MD during
the critical period [16]. Cats recovered close to normal visual
acuity and visual cortex responses through the deprived eye
if the two eyes’ visual axes were aligned during the period
of binocular vision but not if the animals were strabismic.
With respect to patching treatment, research involving
both animals and humans has proven that the best out-
comes, i.e. the maximal improvement of visual acuity in the
amblyopic eye without compromising vision in the fellow
eye, is achieved by part-time occlusion (Figure 1). Only if
reverse occlusion is carried out for 50% of daylight hours
will everyday vision in the initially deprived (amblyopic) eye
recover without acuity of the fellow eye being compromised
(Figure 1A) [17]. Conversely, if kittens are part-time monocu-
larly deprived by wearing an eye patch on a daily basis, then
this has no detrimental effect on visual cortex responses or
acuity as long as about 30% or 2 hours of daily binocular
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Figure 2. Dark exposure promotes recovery from amblyopia.
Amblyopia was induced by monocular lid suture in kittens aged
30 days. After re-opening the eye seven days later, visual acuity was
assessed daily for both eyes in an orientation discrimination task.
Acuity in the non-deprived eye (dotted curve) increased steadily to
reach adult levels by 90 days of age. The animal was initially blind in
the deprived eye (solid line); vision improved gradually but reached
a plateau by 90 days of age at roughly half of normal acuity. After
10 days in a dark-room, acuity in the amblyopic eye suddenly
increased within a few days to that of the fellow eye. Figure adapted
from [50].
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R938visual experience are provided (Figure 1B) [18,19]. Children
wearing an eye patch that objectively monitors the time
the patch is worn similarly show near-maximal improvement
of acuity in the amblyopic eye if the fellow eye is occluded for
just 4–5 hours a day, meaning that there is little benefit from
patching 12 hours a day (Figure 1C) [20,21]. The Pediatric Eye
Disease Investigator Group similarly failed to find significant
additional benefits when comparing acuity outcomes for
prescribed patching doses of 6 hours and 12 hours a day [1].
What Are the Prospects for Treating Amblyopia
in Teenagers and Adults?
Any treatment has to be preceded by correction of the
underlying ocular deficits, such as a combination of optical
measures, surgery on the extra-ocular muscles, or orthoptic
training in case of strabismic amblyopia, or optimal refraction
in case of anisometropic amblyopia. Patching treatment is
generally only effective when started before the age of 8,
and even then amblyopia recurs in 27% of cases, with the
rate of recurrence being higher in younger children [22].
No drug treatment of amblyopia is currently available, but a
number of avenues are being explored based on present
knowledge of critical period control (for a review see [23]).
These either aim at altering the E/I balance in a way that
favours increased plasticity or at removing structural obsta-
cles to plasticity. For example, pharmacological reduction
of GABAergic inhibition in adult rat visual cortex by infusing
either picrotoxin or 3-mercaptopropionic acid for one week
facilitates OD plasticity [24]. While this approach is obviously
not immediately suitable for clinical use, the ability of the
antidepressant fluoxetine to reactivate cortical plasticity is
much more promising. Fluoxetine is a selective serotonin
reuptake inhibitor whose chronic administration not only re-
sults in increased expression of BDNF and reduced levels
of extracellular GABA but also re-instates long-term potenti-
ation (LTP) in response to theta burst stimulation in adult rat
visual cortex [25]. Fluoxetine-treated adult rats exhibit bothan OD shift in response toMD and recovery of vision in a pre-
viously deprived eye [25]. The Finnish pharmaceutical com-
pany Hermo Pharma Ltd (which was co-founded by one of
the authors of the study by Maya Vetencourt and colleagues
[25]) has completed a phase II clinical trial of HER-801 for
treatment of amblyopia in adults, the active component of
which is fluoxetine (http://www.hermopharma.com/pipeline).
Another pharmacological intervention that is currently un-
dergoing a clinical trial is supplementation of occlusion with
carbidopa and levodopa (Jaeb Center for Health Research,
USA; http://clinicaltrials.gov/ct2/show/NCT01190813), which
act by increasing dopamine levels. This approach has been
reported to result in greater improvement of vision over
patching alone, especially in older children, in some studies
[26] but not in others [27]. Compared with fluoxetine, the
biological underpinnings of the supposed enhancement of
cortical plasticity by increasing dopamine levels are less
clear, although depletion of catecholamines has been re-
ported to disrupt OD plasticity [28] and local infusion of
noradrenalin has been reported to restore it [29].
Other promising targets for drug development are aimed
at overcoming structural barriers to plasticity. Pioneering
work in the field of spinal cord injury suggests some leads
for the treatment of amblyopia. For example, cleavage of
CSPGs such as aggrecan by the bacterial enzyme chondroi-
tinase, injected into the visual cortex of adult rats, can
restore ocular dominance plasticity [30] and even promote
recovery from long-term monocular deprivation [31]. How-
ever, similar treatment was less successful in cats [32],
underlining the need for caution when extrapolating from
rodents (who have both a lower level of juvenile plasticity
and a greater degree of ‘adult’ plasticity beyond the end of
the classical critical period) to higher mammals. Another
approach is to remove the blockade to neurite outgrowth in
the CNS caused by myelin, specifically Nogo-A. Function-
blocking Nogo-A antibodies are undergoing clinical trials
for the treatment of spinal cord injury, having been shown
to promote regenerative and compensatory sprouting of
fibres and formation of new connections in the spinal cord
and functional recovery in animalmodels of spinal cord injury
[33]. Mice lacking either Nogo-A or its receptor NgR display
OD plasticity well into adulthood [14], but whether Nogo-A
antibodies can restore visual cortex plasticity in adult wild
type animals has not been tested yet.
Non-Invasive Treatment of Amblyopia
Both animal and human studies indicate that amblyopia may
be treatable using appropriate sensory stimulation alone.
In animal studies two very different strategies have proven
successful; in one, so-called environmental enrichment
maximises sensory (including, but not limited to, visual) stim-
ulation to increase cortical plasticity through a reduction of
intracortical inhibition, and this promotes recovery from
MD in adult rats [34]. One caveat for the application of this
finding to treating human amblyopia is the fact that humans
live in a less ‘impoverished’ environment than laboratory rats
and therefore effective enrichment may be harder to provide.
It should also be pointed out that the effects of monocular
deprivation on rodent vision are much less severe to begin
with than those in higher mammals and humans. At the other
extreme, a period of time spent in total darkness can restore
cortical plasticity and lead to partial recovery of visual acuity
in adult rats [35] while it enables a fast and complete recov-
ery from amblyopia in cats (Figure 2) [36]. These results are
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Figure 3. Binocular treatment of amblyopia using a video game.
Amblyopic subjects dichoptically view a version of Tetris in which the
contrast of the blocks visible to the fellow eye has been reduced in or-
der to match the subjective appearance of the blocks visible to the
amblyopic eye. In one variant (shown here), the blocks on the bottom
are seen by both eyes. The falling piece is divided so that its whole
shape is only seen if both eyes combine the information together,
with one of its four blocks visible to the amblyopic eye, one block to
the fellow eye, and the remaining two blocks to both eyes. In the
second variant, the lower layer of the blocks is visible to both eyes,
high contrast in the amblyopic eye and low contrast in the fellow eye;
the upper layer of blocks, in low contrast, are presented only to the
fixing (non-amblyopic) eye. Figure after [48].
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R939remarkable but at this point it is unknown whether they can
be translated into treatment for humans given that prolonged
periods in total darkness are unlikely to be attractive to
patients, unless it can be established that a less extreme
form of visual deprivation can also be effective.
Another very different strategy aimed at reducing intra-
cortical inhibition or altering the E/I balance involves
repetitive transcranial magnetic stimulation (rTMS) or trans-
cranial direct current stimulation (tDCS) applied to the visual
cortex. Both techniques can transiently improve contrast
sensitivity of adult amblyopes [37,38], and theta-burst
rTMS has recently been reported to improve contrast sensi-
tivity for up to 78 days later [39].
The most successful non-invasive treatments of human
amblyopia are all based on ‘training’ vision through the
amblyopic eye. Several studies have employed perceptual
learning paradigms to improve various aspects of vision in
the amblyopic eye (for a review see [40]). A major drawback
of most perceptual learning paradigms is that the improve-
ments are specific to the trained task and do not transfer
readily to other tasks. However, some exceptions have
been reported [41]. Moreover, perceptual learning that re-
duces crowding in central vision of amblyopes has been
shown to also improve standard measures of visual acuity
[42]. An alternative approach is the use of video games for
training. In the case of action video games, vision is thought
to be improved by engaging attentional mechanisms [43,44].
A different approach is embodied in video games that require
both eyes to cooperate. Eastgate and colleagues developed
a virtual reality display system on which interactive games
are played via stereo display, with different elements of the
‘scene’ visible to the two eyes (at the same contrast) [45].
An uncontrolled pilot study recently found a clinically signif-
icant improvement in acuity in 6 out of 9 amblyopic patients
[46]. In contrast, Hess and colleagues start from the premise
that lack of recovery from amblyopia is caused by interocular
suppression which is stronger going from the fellow to the
amblyopic eye than vice versa [47]. By using dichopticstimulation, with the contrast of the stimuli presented to
the good eye reduced to match the appearance of the
same stimuli when shown to the amblyopic eye, suppression
can be alleviated, allowing greater plasticity than when the
good eye is simply occluded. Improvements in vision in
the amblyopic eye are therefore seen as a consequence of
the reduction in suppression. Hess and colleagues devel-
oped a version of the video game Tetris that can be played
on an iPod and is viewed dichoptically, with blocks visible
to the good eye displayed at a lower contrast than those
visible to the amblyopic eye such that they appeared the
same to the two eyes (Figure 3) [48]. After playing the game
for 1 hour each day for 2 weeks subjects exhibited sig-
nificantly greater improvement in visual acuity and stereop-
sis when training had been dichoptic rather than using just
the amblyopic eye [49].
Conclusion
Given the number of treatment strategies that have been
advanced in recent years, including several that have
reached the clinical trial stage there is hope that applying
our knowledge of visual cortex plasticity will lead to a break-
through in treating amblyopia in childhood and beyond in
the not too distant future.References
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